Related Experiment Video
Updated: Dec 17, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
The Great Masquerader: Tuberculosis Presenting as Community-Acquired Pneumonia
Keertan Dheda1,2, Edson Makambwa1, Aliasgar Esmail1
1Centre for Lung Infection and Immunity, Division of Pulmonology, Department of Medicine and UCT Lung Institute & South African MRC/UCT Centre for the Study of Antimicrobial Resistance, University of Cape Town, Cape Town, South Africa.
Tuberculosis (TB) is a significant cause of community-acquired pneumonia (CAP) globally, especially in certain regions. This review covers TB CAP epidemiology, diagnosis, and management.
Area of Science:
- Infectious Diseases
- Pulmonology
- Global Health
Background:
- Tuberculosis (TB) and lower respiratory tract infections (LRTIs) are leading global causes of death.
- Combined, TB and community-acquired pneumonia (CAP) rank as the third leading cause of death worldwide.
- While Streptococcus pneumoniae is the most common cause of CAP globally, Mycobacterium tuberculosis is a significant, often underestimated, cause in regions like sub-Saharan Africa, Asia, and South America.
Purpose of the Study:
- To review the epidemiology, immunopathogenesis, clinical presentation, diagnosis, management, prognosis, and prevention of TB CAP.
- To highlight the importance of TB as a cause of CAP in specific global settings.
- To discuss the utility of newer diagnostic approaches for TB CAP.
Main Methods:
- Literature review focusing on TB CAP.
- Synthesis of data on epidemiology, clinical aspects, and diagnostics.
- Discussion of management and prevention strategies.
Main Results:
- TB is a frequent cause of CAP in certain regions, with up to one-third of cases attributable to Mycobacterium tuberculosis.
- TB remains a critical clinical issue in intensive care units in affected areas.
- Limited data exist on TB CAP, underscoring the need for further research and awareness.
Conclusions:
- TB CAP is a significant public health concern in many parts of the world.
- Comprehensive understanding and improved diagnostic tools are crucial for effective management.
- Further research is needed to address the knowledge gaps in TB CAP.
More Related Videos
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
07:27Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa
Published on: July 12, 2018
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...